Changes in proportion and function of peripheral CD4+LAP+ regulatory T cells in children with asthma

LUO Jing-Hua; YANG Liang-An; LI Guo-Lin

doi:10.7499/j.issn.1008-8830.2016.08.011

PDF(1366 KB)

Chinese Journal of Contemporary Pediatrics ›› 2016, Vol. 18 ›› Issue (8) : 726-730. DOI: 10.7499/j.issn.1008-8830.2016.08.011

CLINICAL RESEARCH

Changes in proportion and function of peripheral CD4⁺LAP⁺ regulatory T cells in children with asthma

LUO Jing-Hua¹, YANG Liang-An², LI Guo-Lin¹

Author information +

History +

Abstract

Objective To investigate the changes in the proportion and function of peripheral CD4⁺LAP⁺regulatory T cells (CD4⁺LAP⁺Treg cells) in children with asthma, as well as the role of CD4⁺LAP⁺Treg cells in the pathogenesis of asthma. Methods A total of 75 children who were diagnosed with asthma from March 2014 to September 2015 were enrolled as study subjects, and according to their conditions, they were divided into acute-stage asthma group (40 children) and remission-stage asthma group (35 patients). Another 30 children who underwent physical examination were enrolled as the healthy control group. Flow cytometry was used to determine the percentage of peripheral CD4⁺LAP⁺Treg cells, and[3H]-thymidine incorporation assay was performed to analyze the immunosuppression of CD4⁺LAP⁺Treg cells in each group. Results The acute-stage asthma group showed significant reductions in the proportion of CD4⁺LAP⁺Treg cells compared with the remission-stage asthma group and the healthy control group (2.0%±1.0% vs 4.1%±2.4%/4.6%±3.0%; P < 0.05). The acute-stage asthma group also showed a significant reduction in the immunosuppression rate of CD4⁺LAP⁺Treg cells compared with the remission-stage asthma group and the healthy control group (21%±4% vs 55%±9%/62%±11%; P < 0.05). Conclusions In children with asthma, the reduction in the number and inhibitory function of peripheral CD4⁺LAP⁺Treg cells may be involved in the pathogenesis of asthma.

Key words

CD4⁺LAP⁺regulatory T cell / Asthma / Child

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

LUO Jing-Hua, YANG Liang-An, LI Guo-Lin. Changes in proportion and function of peripheral CD4⁺LAP⁺ regulatory T cells in children with asthma[J]. Chinese Journal of Contemporary Pediatrics. 2016, 18(8): 726-730 https://doi.org/10.7499/j.issn.1008-8830.2016.08.011

References

[1] Holgate ST.Innate and adaptive immune responses in asthma[J].Nat Med,2012,18(5):673-683.
[2] Gandhi R,Farez MF,Wang Y,et al.Cutting edge:human latency-associated peptide+T cells:a novel regulatory T cell subset[J].J Immunol,2010,184(9):4620-4624.
[3] Rezende RM,Oliveira RP,Medeiros SR,et al.Hsp65-producing Lactococcus lactis prevents experimental autoimmune encephalomyelitis in mice by inducing CD4⁺LAP⁺ regulatory T cells[J].J Autoimmun,2013,40:45-57.
[4] Wu HY,Center EM,Tsokos GC,et al.Suppression of murine SLE by oral anti-CD3:inducible CD4⁺CD25-LAP⁺ regulatory T cells control the expansion of IL-17⁺ follicular helper T cells[J].Lupus,2009,18(7):586-596.
[5] 中华医学会儿科学分会呼吸学组,《中华儿科杂志》编辑委员会.儿童支气管哮喘诊断与防治指南[J].中华儿科杂志,2008,46(10):745-753.
[6] 沙莉,邵明军,刘传合,等.2010年与2000年中国城市儿童支气管哮喘患病率比较[J].中华结核和呼吸杂志,2015,38(9):664-668.
[7] Jiang H,Wu X,Zhu H,et al.Foxp3(+) Treg/Th17 cell imbalance in lung tissues of mice with asthma[J].Int J Clin Exp Med,2015,8(3):4158-4163.
[8] 潘珍珍,李羚,郭赟,等.CD4⁺CD25⁺Foxp3⁺调节性T细胞与IL-33在儿童哮喘发病机制中的作用[J].中国当代儿科杂志,2014,16(12):1211-1214.
[9] Zhu M,Liang Z,Wang T.Th1/Th2/Th17 cells imbalance in patients with asthma with and without psychological symptoms[J].Allergy Asthma Proc,2016,37(2):148-156.
[10] Chauhan A,Singh M,Agarwal A,et al.Correlation of TSLP,IL-33,and CD4⁺CD25⁺Foxp3⁺T regulatory (Treg) in pediatric asthma[J].J Asthma,2015,52(9):868-872.
[11] Samson M,Audia S,Janikashvili N,et al.Brief report:inhibition of interleukin-6 function corrects Th17/Treg cell imbalance in patients with rheumatoid arthritis[J].Arthritis Rheum,2012,64(8):2499-2503.
[12] Ohl K,Tenbrock K.Regulatory T cells in systemic lupus erythematosus[J].Eur J Immunol,2015,45(2):344-355.
[13] Oida T,Zhang X,Goto M,et al.CD4⁺CD25-T cells that express latency-associated peptide on the surface suppress CD4⁺CD45RB^high- induced colitis by a TGF-beta-dependent mechanism[J].J Immunol,2003,170(5):2516-2522.
[14] Scurr M,Ladell K,Besneux M,et al.Highly prevalent colorectal cancer-infiltrating LAP⁺Foxp3^-T cells exhibit more potent immunosuppressive activity than Foxp3⁺ regulatory T cells[J].Mucosal Immunol,2014,7(2):428-439.
[15] Stelmaszczyk-Emmel A,Zawadzka-Krajewska A,Szypowska A,et al.Frequency and activation of CD4⁺CD25⁺Foxp3⁺ regulatory T cells in peripheral blood from children with atopic allergy[J].Int Arch Allergy Immunol,2013,162(1):16-24.
[16] Duan W,So T,Mehta AK,et al.Inducible CD4⁺LAP⁺Foxp3^- regulatory T cells suppress allergic inflammation[J].J Immunol,2011,187(12):6499-6507.
[17] Zhu ZF,Tang TT,Dong WY,et al.Defective circulating CD4⁺LAP⁺regulatory T cells in patients with dilated cardiomyopathy[J].J Leukoc Biol,2015,97(4):797-805.
[18] Tang XQ,Sun WP,Xu HB,et al.The changes in the levels of IL-6,IL-17,and IL-21 in the acute stage of childhood asthma[J].Clin Lab,2013,59(11-12):1381-1387.